C......
Full article >>> '"/>
Source:wistechnology.com By Michael Rosen 12/18/06
Page: 1 2 3 4 5 Related biology technology :
1. 2006: A mixed blessing for Midwest life science companies 2. DEMO 2006: A sea change is coming 3. Are you doomed to repeat the great software mistake? 4. Some great insights into the current Mergers & Acquisitions Market 5. Secrets of a great demo 6. Norlight offers bonus for great IT referrals 7. Midwest health care technology luring greater investment focus 8. Human stem cells called great opportunity for drug discovery 9. Historic lists - The greatest rock bands, rock guitarists of all time 10. Networking for your employer is great for building your personal Rolodex 11. The greatest life-science developments of 2004
(Date:3/12/2010)... Inc. (Pink Sheets: VRML) today announced that Medicare will cover OVA1™, a ... or malignant. Highmark Medicare Services is the CMS contractor that will process ... new service. , ... ... ... (Date:3/11/2010)... March 11 Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® ... , ... , , ... ... ... (Date:3/11/2010)... RATON, Fla. , March 11 ... Stem Cell Assurance is pleased to announce the inclusion ... Dr. Joseph J. Ross , M.D., F.A.C.S. Dr. ... company in March 2010 . Stem Cell Assurance ... physician network designed to provide medical and cosmetic procedures ... (Date:3/11/2010)... at Philadelphia Conference , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced it will ... Bank and Cowen & Company at CBI,s 2010 Accounting and ... attended each year by over 300 finance, accounting, audit and ... Breaking Biology Technology:Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test 2Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test 3Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test 4FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 2FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 3FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 4FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 5FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 6FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 7FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 8Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman 2Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman 3Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman 4ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 2ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 3... 20 Academia, science, industry,and government leaders gathered ... the Dedication and Open House celebration for the ... Research Building and the NC,State Fruit and Vegetable ... home to NC A&T University, NC Central University, ... ... The implementation of a,compliant Laboratory Information Management System ... by "scope creep," with costs,rising 2 to 5 ... of a seemingly never-ending project. But a new ... promises to cut the technical,resources and costs required ... ... BOZEMAN, Mont., Oct. 20 Sustainable Oils ... biotechnology industry,professional as the company,s general manager. ... continuing efforts to build camelina,production and marketing ... Canada. Johnson joined the company on Oct. ... Other Biology Technology:Campus Celebrates Historic Milestone 2Campus Celebrates Historic Milestone 3Campus Celebrates Historic Milestone 4Campus Celebrates Historic Milestone 5White Paper Examines New 'Thin LIMS' IT Implementation Strategy for cGMP Quality Informatics 2Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production 2Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production 3Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production 4(Date:3/12/2010)... is available in Spanish . , Scientists ... for Research in Biomedicine (IRB Barcelona), reveal a surprising ... one known to date. Found in the cell membrane, ... expression of genes that make the cell divide, grow, ... the correct development of organisms and for the maintenance ... (Date:3/12/2010)... depths of caves are throwing light on a long-held ... to a new phylogenetic analysis of the family Typhlochactidae, ... and in leaf litter) evolved independently on more than ... the surface (in caves). The research, currently available in ... April issue of Cladistics . , "Our research ... (Date:3/12/2010)... 50% of humans worldwide, can cause stomach ulcers and, in ... Medicine Reports , Seiji Shiota and Yoshio Yamaoka discuss the ... Infection by the H. pylori bacterium can approach ... symptoms, but many develop problems including stomach ulcers. H. ... and can also contribute to the development of gastric cancer, ... Breaking Biology News(10 mins):Opposing functions of a key molecule in the development of organisms 2Opposing functions of a key molecule in the development of organisms 3Phylogenetic analysis of Mexican cave scorpions suggests adaptation to caves is reversable 2Phylogenetic analysis of Mexican cave scorpions suggests adaptation to caves is reversable 3Preventing gastric cancer with antibiotics 2Betsy McCaughey Rallies to Protect Seniors 26 Your Healthcare Choices 52987 1Betsy McCaughey Rallies to Protect Seniors 26 Your Healthcare Choices 52987 2Courage Center Welcomes Susan Oswald as Major Gifts Director 52985 1Courage Center Welcomes Susan Oswald as Major Gifts Director 52985 2Martek to Present at Upcoming Canaccord Adams Conference 52983 1CMRL Medium-1066 (1X) liquid... ... biosynthesized by the 11(R)-LOs of the ... fresh water hydra, H. vulgaris. The ... oocyte maturation and tentacle regeneration, respectively, ... produced when aspirin-treated recombinant COX-2 is ... ... (PEBP) does not share significant homology ... PEBP is expressed in the central ... and stomach. One important role ... inhibitory activity against several serine proteases ... ... The PowerEase 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple intuitive ... Biology Products:Biology NavigationMedical Navigation
|